- DRAP has authorized the emergency use of one other Chinese language vaccine, CoronaVac.
- This may be the fifth coronavirus vaccine and the third Chinese language vaccine for use in Pakistan.
- UK’s AstraZeneca and Russian Sputnik V vaccines have additionally been given Emergency Use Authorisation in Pakistan.
KARACHI: Amid the intensifying third COVID-19 wave, the Drug Regulatory Authority of Pakistan (DRAP) has granted Emergency Use Authorization (EUA) to a different Chinese language vaccine, CoronaVac, officers instructed The Information on Thursday.
This may be the fifth coronavirus vaccine and the third Chinese language vaccine for use in Pakistan.
Earlier, Pakistan had granted the EUA to China’s two-dose Sinopharm and single-dose Convidecia vaccine developed by the Cansino Biologicals Inc. UK’s AstraZeneca and Russian Sputnik V vaccines have additionally been authorized by the DRAP.
In line with the report, the CoronaVac vaccine, regardless of its low efficacy price was allowed by the well being authorities to counter the third wave of the pandemic in Pakistan.
On this regard, an official of the Drug Regulatory Authority mentioned: “DRAP’s registration board in its 304th assembly on Thursday gave Emergency Use Authorisation (EUA) to CoronaVac vaccine, developed by the Sinovac Life Sciences Firm Ltd., based mostly in Beijing, China.”
Read more: Coronavirus vaccination centres in Pakistan to remain closed on Fridays
Which vaccines are being used currently
Two Chinese and one Russian vaccine are being used in the public and private sectors, officials said.
Pakistan is expecting the AstraZeneca vaccine under the COVAX programme but due to supply constraints, the country has not received its share of doses as yet.
The DRAP official further said an expert committee had recommended emergency use authorisation for the CoronaVac vaccine, although its data was not published and overall efficacy was around 56%.
“But in Turkey and Indonesia, the efficacy of CoronaVac has been found to be 91.25% and 85.3% respectively. Besides, it is already being used in China, Turkey, Indonesia, Brazil, and some Middle Eastern countries,” the DRAP official added.
‘We desperately want vaccines in Pakistan’
The DRAP official additional mentioned that the corporate offered its security and efficacy information to the skilled committee and on its suggestions, the approval was given.
“The DRAP’s registration board allowed the vaccine as we desperately need vaccines in Pakistan,” the official asserted.
The CoronaVac is a conventional vaccine, which will be saved at 2-8°C, which makes it best for nations like Pakistan the place they don’t have extremely chilly chain fridges.
Furthermore, section III medical trials of a triple-dose Chinese language vaccine, developed by the Anhui Zhifei Longcom Biopharmaceutical Firm Ltd, are additionally underway in Lahore, Faisalabad, and different cities of Pakistan.